PS 14-35 INFLUENCE OF AZILSARTAN MEDOXOMIL ON CENTRAL AORTIC BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. (September 2016)
- Record Type:
- Journal Article
- Title:
- PS 14-35 INFLUENCE OF AZILSARTAN MEDOXOMIL ON CENTRAL AORTIC BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION. (September 2016)
- Main Title:
- PS 14-35 INFLUENCE OF AZILSARTAN MEDOXOMIL ON CENTRAL AORTIC BLOOD PRESSURE AND AMBULATORY BLOOD PRESSURE IN PATIENTS WITH MILD TO MODERATE ESSENTIAL HYPERTENSION
- Authors:
- Dobrokhod, Anna
Sirenko, Yuriy
Zhivilo, Irina
Torbas, Olena
Granich, Vladimir
Radchenko, Anna
Primac, Galina
Sydorenko, Piotr
Polishchuk, Sergey
Kushnir, Svetlana - Abstract:
- Abstract : Objective: This study was planned to assess influence of azilsartan medoxomil (AZL) on central aortic blood pressure (CAP) and 24-hours blood pressure (BP) in patients with mild to moderate hypertension. Design and Method: Twenty-nine patients (75% men, all white, mean age – 43 years) with mild to moderate essential hypertension, never treated before, were enrolled. Dose of AZL was gradually increased until maximum 80 mg once-daily. Follow-up of the study amounted to 6 months. CAP measurement (SphygmoCor CVMS, Atcor, Australia) and 24-hours blood pressure monitoring (ABPM, Meditech, Hungary) were measured before treatment and on the last visit. Results: Mean value (mean ± SEM) of baseline 24-hours systolic BP (SBP) was 144 ± 1.8 mmHg and 24-hours diastolic BP (DBP)–85 ± 1.6 mmHg, while mean value of CAP was 139 ± 2.9 mmHg. At the end of the study mean value of 24-hours SBP was 128 ± 1.9 mmHg, 24-hours DBP–77 ± 2.1 mmHg and CAP was 121 ± 3, 0 mmHg. So decrease from baseline to final CAP, 24-hours SBP and 24-hours DBP were −18, −16 and −8 mmHg respectively. An outcome of the study shows a significant reduction in both 24-hours SBP and DBP (p < 0.0001) and CAP changes (p < 0.005). Conclusions: Once-daily AZL effectively lowers CAP in adults with mild to moderate essential hypertension and has shown good antihypertensive efficacy according to 24-hours blood pressure monitoring as well.
- Is Part Of:
- Journal of hypertension. Volume 34:(2016) Supplement 1
- Journal:
- Journal of hypertension
- Issue:
- Volume 34:(2016) Supplement 1
- Issue Display:
- Volume 34, Issue 1 (2016)
- Year:
- 2016
- Volume:
- 34
- Issue:
- 1
- Issue Sort Value:
- 2016-0034-0001-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-09
- Subjects:
- Hypertension -- Periodicals
Hypertension -- Periodicals
616.132005 - Journal URLs:
- http://firstsearch.oclc.org ↗
http://journals.lww.com/jhypertension/pages/default.aspx ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=yrovft&AN=00004872-000000000-00000 ↗
http://www.jhypertension.com/ ↗
http://journals.lww.com/pages/default.aspx ↗ - DOI:
- 10.1097/01.hjh.0000501158.47506.d6 ↗
- Languages:
- English
- ISSNs:
- 1473-5598
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5004.510000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 11126.xml